The latest news in renal cancer
New study describes overactivated signaling in renal cell cancer
In a new study from the Johns Hopkins Kimmel Cancer Center, researchers described a novel…
Browsing: Kidney Cancer
Gene signature points to prognosis in kidney cancer
Among patients with kidney cancer, the activity of four specific genes in the cancer cells…
Robotic kidney cancer surgery shows desirable outcomes in study
Kidney cancer is not always confined to the kidney. In advanced cases, this cancer invades the…
Anti-rejection medication and immunotherapy kicks cancer and protects kidney transplants
Adding immunotherapy to standard anti-rejection medication could change the lives of thousands of kidney transplant…
NICE recommends nivolumab plus ipilimumab for untreated advanced kidney cancer in intermediate or poor-risk patients
Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care Excellence…
Researchers shine light on a rare form of kidney cancer
Translocation renal cell carcinoma (tRCC) is a rare and aggressive form of kidney cancer. It…
The new Australian innovation set to transform treatment of kidney cancer
One of the biggest challenges treating kidney cancer is the wide number of tumour types…
Immunotherapy may yield longer treatment-free survival in renal cell carcinoma patients
Patients with advanced renal cell carcinoma who received the checkpoint inhibitor combination nivolumab plus ipilimumab experienced longer treatment-free survival…
Children in the UK and Ireland still diagnosed later with larger kidney cancers than in rest of Europe
Children with kidney cancers continue to be diagnosed with larger and more advanced tumours in…
New immunotherapy insights for kidney cancer
Researchers at the Francis Crick Institute, The Royal Marsden NHS Foundation Trust, UK, and UCL,…